help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2006-0269
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
21/3/613    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nair, S. S.
Right arrow Articles by Vadlamudi, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nair, S. S.
Right arrow Articles by Vadlamudi, R. K.
Molecular Endocrinology 21 (3): 613-624
Copyright © 2007 by The Endocrine Society

Proline-, Glutamic Acid-, and Leucine-Rich Protein-1/Modulator of Nongenomic Activity of Estrogen Receptor Enhances Androgen Receptor Functions through LIM-Only Coactivator, Four-and-a-Half LIM-Only Protein 2

Sujit S. Nair, Zhiyong Guo, Judith M. Mueller, Shahriar Koochekpour, Yun Qiu, Rajeshwar Rao Tekmal, Roland Schüle, Hsing-Jien Kung, Rakesh Kumar and Ratna K. Vadlamudi

Department of Obstetrics and Gynecology (S.S.N., R.R.T., R.K.V.), University of Texas Health Science Center, San Antonio, Texas 78229; Department of Microbiology and Immunology and Stanley S. Scott Cancer Center (S.K.), Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112; Universitaets-Frauenklinik und Zentrale Klinische Forschung (J.M.M., R.S.), D-79106 Freiburg, Germany; Department of Pharmacology and Experimental Therapeutics (Z.G., Y.Q.), University of Maryland School of Medicine, Baltimore, Maryland 21201; Department of Biological Chemistry (H.-J.K.), University of California at Davis, Sacramento, California 95817; and The University of Texas MD Anderson Cancer Center (R.K.), Houston, Texas 77030

Address all correspondence and requests for reprints to: Ratna K. Vadlamudi, Department of Obstetrics and Gynecology, University of Texas Health Science Center, Floyd Curl Drive, San Antonio, Texas 78229-3900. E-mail: vadlamudi{at}uthscsa.edu.

Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1) is a coregulator of multiple nuclear receptors. Molecular mechanisms of PELP1 function are not completely understood, but its expression is up-regulated in hormonal-dependent cancers. Using a yeast two-hybrid screen, we found that four-and-a-half LIM-only protein 2 (FHL2) interacted with PELP1. FHL2 is a transcriptional regulator that associates with nuclear cofactors, including androgen receptors (ARs), and contains an intrinsic activation domain. PELP1 and FHL2 interact in vitro and in vivo and colocalize in the nuclear compartment. PELP1 interacts with FHL2 via LIM domains 3 and 4 and synergistically enhances the transcriptional activity of FHL2. Src kinase is required for PELP1-mediated enhancement of FHL2 functions because knockdown of Src kinase expression or function abolished PELP1-mediated FHL2 activation functions. PELP1 interacted with AR and enhanced FHL2-mediated AR transactivation functions. PELP1 knockdown by small interfering RNA or PELP1 mutant, which lacks an activation domain, reduced FHL2-mediated AR transactivation. Biochemical analyses revealed a complex consisting of PELP1, FHL2, and AR in prostate cancer cells. PELP1/MNAR expression was elevated in high-grade prostate tumors. Our results suggest that PELP1 functions as a molecular adaptor, coupling FHL2 with nuclear receptors, and PELP1-FHL2 interactions may have a role in prostate cancer progression.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR
Coregulators:   FHL2  |  PELP1
Ligands:   R1881



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Bai, J. Zha, H. Zhao, F. P. Ross, and S. L. Teitelbaum
Tumor Necrosis Factor Receptor-associated Factor 6 Is an Intranuclear Transcriptional Coactivator in Osteoclasts
J. Biol. Chem., November 7, 2008; 283(45): 30861 - 30867.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Dimple, S. S. Nair, R. Rajhans, P. R. Pitcheswara, J. Liu, S. Balasenthil, X.-F. Le, M. E. Burow, N. Auersperg, R. R. Tekmal, et al.
Role of PELP1/MNAR Signaling in Ovarian Tumorigenesis
Cancer Res., June 15, 2008; 68(12): 4902 - 4909.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. V. Heemers and D. J. Tindall
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Endocr. Rev., December 1, 2007; 28(7): 778 - 808.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. V. Heemers, K. M. Regan, S. M. Dehm, and D. J. Tindall
Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer
Cancer Res., November 1, 2007; 67(21): 10592 - 10599.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society